Por: Fox Business Business October 20, 2022
Check out what's clicking on FoxBusiness.com Abbott Laboratories CEO Robert Ford said Wednesday the company has made progress in addressing the ongoing baby formula shortage in the U.S. over the past several months, providing a status update and revealing changes aimed at preventing another crisis. A general view of the Abbott Healthcare Nutrition plant in Cootehill Co Monaghan. (Niall Carson/PA Images via Getty Images / Getty Images)Ticker... + full article
CNN USA Health October 20, 2022
CNN — Abbott Nutrition plans to build a $500 million nutrition facility for specialty and metabolic infant formulas, Chairman and CEO Robert Ford said Wednesday. The announcement comes as the US formula shortage continues and experts have called for more domestic... + más
‘If the FDA is expected to do more, it needs more’: FDA investigation into baby-formula crisis points to its own shortcomings. But shortages persist. | MarketWatch
Abbott launches new infant formula recall at another plant for faulty bottle cap seals | ABC News
CNN USA Health October 18, 2022
CNN — Despite improving stock rates, many families with new babies in the United States are still having trouble finding baby formula. Data from market research firm IRI shows that the share of powdered baby formula products that are out of stock in the US has nearly been... + más
ABC News USA Health October 15, 2022
In a new recall following a separate one which dogged them for the better part of this year, Abbott, which has been the largest infant formula manufacturer in the U.S., is now voluntarily recalling bottles of their largest, most popular kind of formula, Similac, from their... + más
Abbott issues new baby formula recall over possibly spoiled products | 10 WBNS
10 WBNS USA Nation October 14, 2022
WASHINGTON — Abbott Labs said Friday it is some ready-to-feed liquid baby formula, citing a bottle cap defect. The recall involves certain lots of 2 fluid ounce/59 milliliter bottles from the brands Similac Pro-Total Comfort, Pedialyte Electrolyte Solution, Similac NeoSure and... + más
The Hill USA Politics October 12, 2022
Sen. Elizabeth Warren (D-Mass.) sent a letter Wednesday to Abbott Nutrition accusing the company of employing “abusive legal tactics” to cover up health risks with its powdered infant formula product — safety concerns she said the business has been aware of for decades. In... + más
MarketWatch USA Business September 24, 2022
“The report also identifies several areas in which the FDA lacks specific authorities and resources. Simply put, if the FDA is expected to do more, it needs more,” he added. Supply-chain disruptions and product recalls from Abbott Laboratories in February due to... + más
FDA concedes delays in response to baby formula shortage | ABC News
Internal FDA report on infant formula crisis details shortfalls in response | ABC News
ABC News USA Health September 21, 2022
An internal review of the Food and Drug Administration's actions leading up to the finds a combination of human error, antiquated technology, and poor communication and accountability amongst an already threadbare food workforce all contributed to a perfect storm of... + más
FDA concedes delays in response to baby formula shortage | Associated Press
About iurex | Privacy Policy | Disclaimer |